Mettler-Toledo International Inc. (MTD)

NYSE: MTD · USD

$1,700

+14.49 (+0.9%)· Recorded snapshot

영어 원본으로 대체KO

번역하는 동안 영어 원본을 표시 중

이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

StockMarketAgent Research · Analyzed 2026-10-05

Our latest published analysis: MTD rated Sell

Mettler-Toledo International Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$891 / share

Potential value

$1,071 / share

Upside to FV

-42.2%

from $1,700

Moat

9/10

Wide

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$30.9B
Revenue (ttm)	4.1B
Net income (ttm)	905.6M
EPS (ttm)	$44.4
Shares out	20M
P/E (trailing)	38.2x
P/E (forward)	28.5x
Volume	128,542
Beta	1.19

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.1B
Net income (ttm): 905.6M
EPS (ttm): $44.4
P/E (trailing): 38.2x
P/E (forward): 28.5x
Market cap: $30.9B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$3.72B	$3.92B	$3.79B	$3.87B	$4.03B	+2.0%
Gross profit	$2.17B	$2.31B	$2.24B	$2.33B	$2.39B	+2.4%
Operating income	$994.7M	$1.13B	$1.15B	$1.13B	$1.12B	+3.0%
Net income	$769.0M	$872.5M	$788.8M	$863.1M	$869.2M	+3.1%
EPS (diluted)	$32.78	$38.41	$35.90	$40.48	$42.05	+6.4%
EBITDA	$1.10B	$1.24B	$1.15B	$1.25B	$1.24B	+3.1%
R&D	$169.8M	$177.1M	$185.3M	$189.4M	$199.4M	+4.1%
SG&A	$944.0M	$938.5M	$904.1M	$936.3M	$998.3M	+1.4%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	39.4x	10.8x	101.6%	+6.1%	+28.5%	매도
ABNB	Airbnb, Inc.	97.8B	37.5x	7.4x	16.8%	+24.4%	+28.5%	매도
ADBE	Adobe Inc.	97.1B	13.9x	3.7x	57.2%	+11.5%	-30.7%	적극 매수
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	매도
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	비중 축소
ALGN	Align Technology Inc.	10.9B	26.6x	2.6x	17.2%	+3.6%	+11.6%	비중 축소

Base and Bull scenarios

Base60%

Price target

$891.08

-42.2% from spot

Revenue compounds at 4.5%-5.1% annually, supported by steady 200 bps pricing realization and gradual recovery in Chinese operations, while Western European and US operations sustain mid-single digit cash generation,. Operating margins normalize around 28.1% to 28.7%, and free cash flow generation exceeding $840M supports ongoing annual share count reductions.

Revenue growth averages 4.5% to 5.1% annually through FY2030
Operating margin maintained between 28.06% and 28.75%
Operating tax rate normalized at 19.0%
Capex reinvestment rate maintained at 10-12% of NOPAT
Terminal P/E multiple normalizes to 24.5x

Bull20%

Price target

$1,070.69

-30.5% from spot

Chinese demand inflects positively on government stimulus transmission and replacement cycles, while biopharmaceutical laboratory capex accelerates as interest rates ease. Consolidated organic revenue growth accelerates to 6.5%-7.5% annually, operating margins expand toward 29.5% via operating leverage and SternDrive productivity, and sustained share buybacks drive compounded EPS growth above 12%.

Revenue growth accelerates to 6.5%-7.5% per annum
Operating margin expands toward 29.5% supported by SternDrive efficiencies
Annual pricing realization exceeds 200 bps
Diluted share count contracts by 2.5% annually through buybacks

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($891.08). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.5%	2.8%	3.0%	3.3%	3.5%
8.5%	$979	$1,008	$1,039	$1,073	$1,112
9.0%	$910	$933	$959	$987	$1,017
9.5%	$850	$870	$891	$914	$939
10.0%	$799	$815	$833	$852	$873
10.5%	$753	$767	$782	$799	$816

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.5

P25 n/aP50 n/aP75 n/a

Trailing P/E33.6

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC42.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MTD indicators

Market & fundamental data

Available fields

274

Groups with data

Currency

USD

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001037646
Company name	Mettler-Toledo International Inc.
Country	Switzerland
Country code	US
CUSIP number	592688105
Earnings date	2026-11-05
Earnings time	amc
Employees	18,100
Employees change	800
Employees growth	4.62%
Enterprise value	$36.1B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1991
In index	SP500
Industry	Diagnostics & Research
IPO date	1997-11-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US5926881054
Last 10-K release date	2026-02-06
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$34.1B
Market cap category	Large-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$1,699.83
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	MTD
Website	https://www.mt.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	37.88x
Average P/E ratio (10Y)	35.13x
Average P/E ratio (3Y)	32.07x
Average P/E ratio (5Y)	34.28x
Earnings yield	2.61%
EV/Earnings	39.94x
EV/EBIT	30.31x
EV/EBITDA	28.36x
EV/FCF	41.87x
EV/Sales	8.75x
FCF / EV yield	2.39%
FCF yield	2.53%
Forward EV/Sales	8.36x
Forward P/E	34.45x
Forward P/S	7.87x
Graham number	25.298
Graham upside	-98.51%
Industry forward P/E	30.87x
Industry P/E	50.24x
Lynch fair value	$222.23
Lynch upside	-86.94%
P/(FCF - SBC) ratio	40.53x
P/(OCF - SBC) ratio	35.79x
P/B ratio	2,658.38x
P/E ratio	38.25x
P/FCF ratio	39.46x
P/OCF ratio	34.96x
P/S ratio	8.25x
PEG ratio	3.26x
Price/EBITDA ratio	26.72x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	28.87%
EBITDA margin	30.86%
Effective tax rate	17.47%
FCF margin	20.9%
Gross margin	60.26%
Operating margin	28.87%
Pretax margin	26.55%
Profit margin	21.91%
Profit per employee	$50,034
Profitable quarters	114
Profitable years	28
Revenue per employee	$228,391
ROA	21.1%
ROA (5Y)	20.63%
ROCE	48.31%
ROIC	42.28%
ROIC (5Y)	44.19%
SBC / revenue	0.55%
Tax / revenue	4.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.53%
EPS growth (Q)	18.34%
EPS growth (QoQ)	38.66%
EPS growth 10Y	13.12%
EPS growth 3Y	3.76%
EPS growth 5Y	8.27%
EPS growth quarters	4
EPS growth years	2
FCF growth	1.9%
FCF growth (Q)	33.01%
FCF growth (QoQ)	130.94%
FCF growth 3Y	0.22%
FCF growth 5Y	2.13%
Gross profit growth	7.48%
Gross profit growth (Q)	12.13%
Gross profit growth 3Y	2.01%
Gross profit growth 5Y	4.1%
Net income growth	9.14%
Net income growth (Q)	15.1%
Net income growth (QoQ)	37.44%
Net income growth 3Y	0.63%
Net income growth 5Y	4.91%
Net income growth quarters	4
Net income growth years	2
OCF growth	2.47%
OCF growth (Q)	31.33%
OCF growth (QoQ)	122.05%
OCF growth 10Y	8.65%
OCF growth 3Y	0.21%
OCF growth 5Y	2.07%
Operating income growth	7.74%
Operating income growth (Q)	19.1%
Operating income growth 3Y	0.3%
Operating income growth 5Y	4.87%
Revenue growth	6.91%
Revenue growth (Q)	4.49%
Revenue growth (QoQ)	8.47%
Revenue growth 10Y	5.48%
Revenue growth 3Y	1.49%
Revenue growth 5Y	3.54%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-111.2M
Depreciation and amortization	$82.2M
EBIT	$1.2B
EBITDA	$1.3B
EPS	$44.45
FCF per share	$43.12
Financing cash flow	$-817.1M
Free cash flow	$864M
Free cash flow minus SBC	$841.1M
Gross profit	$2.5B
Income taxes	$191.8M
Investing cash flow	$-172.6M
Net borrowing	$-48.7M
Net cash flow	$-10.4M
Net income	$905.6M
Operating cash flow minus SBC	$952.3M
Operating income	$1.2B
Revenue	$4.1B
Stock-based compensation	$22.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	10.29
Book value per share	$0.64
Debt / EBITDA	1.61
Debt / equity	166.68
Debt / FCF	2.47
Goodwill	$735.2M
Interest coverage	17.21
Long-term assets	$2.3B
Long-term liabilities	$2.5B
Net cash (debt)	$-2.1B
Net cash / market cap	-6.12%
Net debt / EBITDA	1.64
Net debt / equity	162.68
Net debt / FCF	2.41
Piotroski F-Score	7
Property, plant and equipment	$831.9M
Shareholders' equity	$12.8M
Tangible book value	$-988.6M
Tangible book value per share	$-49.34
Total assets	$3.7B
Total cash	$51.4M
Total debt	$2.1B
Total liabilities	$3.7B
WACC	10.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.17
Current assets	$1.3B
Current liabilities	$1.2B
Current ratio	1.12
Inventory turnover	4.11
Net working capital	$187.6M
Quick ratio	0.66
Working capital	$146.9M
Working capital turnover	29.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.98%
Dividend yield	0%
Shareholder yield	2.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	326.97%
10Y return CAGR	15.62%
10Y total return	326.97%
150-day SMA	$1,333.68
15Y price change	978.69%
15Y return CAGR	17.18%
15Y total return	978.69%
1D price change	0.86%
1M price change	12.34%
1M total return	12.34%
1W price change	3.93%
1W total return	3.93%
1Y price change	19.62%
1Y return CAGR	19.63%
1Y total return	19.62%
20-day SMA	$1,601.62
200-day SMA	$1,335.37
20Y price change	2,412.1%
20Y return CAGR	17.49%
20Y total return	2,412.1%
3M price change	27.08%
3M total return	27.08%
3Y price change	73.95%
3Y return CAGR	20.26%
3Y total return	73.95%
50-day SMA	$1,482.55
50-day SMA vs 200-day SMA	50over200
52-week high	$1,722.76
52-week high date	2026-10-28
52-week low	$1,023.05
52-week low date	2026-05-13
5Y price change	16.16%
5Y return CAGR	3.04%
5Y total return	16.16%
6M price change	33.22%
6M total return	33.22%
All-time high	$1,722.76
All-time high date	2026-10-28
All-time low	$14.00
All-time low date	1997-11-14
Average true range (ATR)	$40.45
Average volume	193.1K
Beta (1Y)	0.42
Beta (2Y)	0.91
Beta (5Y)	1.19
Change from 52-week high	-1.33%
Change from 52-week low	66.15%
Change from all-time high	-1.43%
Change from all-time low	12,029.86%
Change from open	0.58%
Day's gap	0.28%
Dollar volume	$218.5M
High price	$1,717.79
Low price	$1,689.97
Monthly RSI	65.43
Open price	$1,689.97
Position in 52-week range	35.44%
Premarket change	0%
Premarket close	$1,685.32
Premarket price	$1,685.32
Previous close	$1,685.32
Price vs 150-day SMA	27.33%
Price vs 20-day SMA	6.03%
Price vs 200-day SMA	27.17%
Price vs 50-day SMA	14.54%
Relative volume	0.67
RSI	76.25
Sharpe ratio	0.6
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	0.14
Sortino ratio	1
Sortino ratio (3Y)	1.03
Sortino ratio (5Y)	0.38
Volume	128.5K
Weekly RSI	71.3
YTD price change	21.8%
YTD total return	21.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.9M
Float percentage	99.45%
Shares change (QoQ)	-0.85%
Shares change (YoY)	-2.98%
Shares held by insiders	0.45%
Shares held by institutions	104.03%
Shares outstanding	20M
Short % of float	3.56%
Short % of shares	3.54%
Short ratio	3.4 days

Deeper analysis on MTD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this MTD report

What is the latest published MTD stock rating?

Mettler-Toledo International Inc. is shown with Sell in the latest published report, analyzed 2026-10-05. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MTD analysis?

The full latest published report, analyzed 2026-10-05, lives at /stocks/MTD/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for MTD?

The latest published report analyzed 2026-10-05 gives MTD a fair value of USD 891 and a potential value of USD 1,071. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the MTD page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-05). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

SellMTD · Fair value $891-42.2%

Read full analysis →

Category	Score	Reading
Valuation	1.5
Management	8.5
Balance Sheet	5.0
Profitability	5.5
Revenue Growth	6.0
Risk Assessment	6.0
Competitive Moat	9.0
Earnings Quality	6.5
Capital Efficiency	8.5

Mettler-Toledo International Inc. (MTD)

Our latest published analysis: MTD rated Sell

Price

Financial snapshot

Fair-value bridge

Latest news · MTD

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All MTD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MTD

Frequently asked questions

등급 이력